Chugai OTC Stock Analysis

CHGCF
 Stock
  

USD 27.00  0.00  0.00%   

The latest Chugai Pharmaceutical price dip could raise concerns from shareholders as the firm is trading at a share price of 27.00 on very low momentum in volume. The company executives were unable to exploit market volatilities in June. However, diversifying your overall positions with Chugai Pharmaceutical can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.64. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Continue to Trending Equities.
  
Refresh
The Chugai Pharmaceutical otc stock analysis report makes it easy to digest most publicly released information about Chugai Pharmaceutical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Chugai OTC Stock analysis module also helps to analyze the Chugai Pharmaceutical price relationship with some important fundamental indicators such as market cap and management efficiency.

Chugai OTC Stock Analysis Notes

About 60.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Chugai Pharmaceutical next dividend is scheduled to be issued on the 29th of June 2022. The entity had a split on the 29th of June 2020. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.The quote for Chugai Pharmaceutical is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Chugai Pharmaceutical please contact Osamu Nagayama at 81 3 3281 6611 or go to https://www.chugai-pharm.co.jp.

Chugai Pharmaceutical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Chugai Pharmaceutical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Chugai Pharmaceutical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Chugai Pharmaceutical generated a negative expected return over the last 90 days
About 60.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Galderma Announces Positive Data From Phase III Trial, Demonstrating Efficacy and Safety of nemolizumab in Patients with Prurigo Nodularis - Yahoo Finance

Chugai Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 44.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chugai Pharmaceutical's market, we take the total number of its shares issued and multiply it by Chugai Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Chugai Profitablity

Chugai Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Chugai Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Chugai Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Chugai Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Chugai Pharmaceutical's profitability requires more research than a typical breakdown of Chugai Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 32.51 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 45.73 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.46.

Management Efficiency

The entity has return on total asset (ROA) of 24.95 % which means that it generated profit of $24.95 on every $100 spent on asset. This is very large. Similarly, it shows return on equity (ROE) of 34.85 %, meaning that it generated $34.85 on every $100 dollars invested by stockholders. Chugai Pharmaceutical management efficiency ratios could be used to measure how well chugai pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 2nd of July, Chugai Pharmaceutical shows the mean deviation of 0.621, and Risk Adjusted Performance of (0.21). Chugai Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for Chugai Pharmaceutical, which can be compared to its rivals. Please confirm Chugai Pharmaceutical treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Chugai Pharmaceutical is priced correctly, providing market reflects its regular price of 27.0 per share. Given that Chugai Pharmaceutical has jensen alpha of (0.26), we suggest you to validate Chugai Pharmaceutical's prevailing market performance to make sure the company can sustain itself at a future point.

Chugai Pharmaceutical Price Movement Analysis

The output start index for this execution was four with a total number of output elements of fifty-seven. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Chugai Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Chugai Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
.

Chugai Pharmaceutical Technical and Predictive Indicators

Chugai Pharmaceutical Forecast Models

Chugai Pharmaceutical time-series forecasting models is one of many Chugai Pharmaceutical's otc stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chugai Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Chugai OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Chugai Pharmaceutical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Chugai shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Chugai Pharmaceutical. By using and applying Chugai OTC Stock analysis, traders can create a robust methodology for identifying Chugai entry and exit points for their positions.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Chugai Pharmaceutical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Piotroski F Score module to get Piotroski F Score based on binary analysis strategy of nine different fundamentals.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.78
Market Capitalization
44.4 B
Quarterly Revenue Growth YOY
1.14
Return On Assets
0.25
Return On Equity
0.35
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.